Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: NGF6-E test formulation
Total 0 results
Nothing found
Sponsors and Collaborators
Maria de las Mercedes Perez Rodriguez
Steven B. Kleiboeker
Donald B. Kohn, M.D.
Didem OZKAL EMINOGLU
Sub-Investigator: Łucja Bieleninik, PhD
Pharmacy Board of Sierra Leone, Ministry of Health and Sanitation
Universidad Mayor de San Simón (UMSS, Bolivia)
The Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona
Nelson Mandela Academic Hospital
Sociedad Panameña de Hematología
Hospital Governador Celso Ramos
Roongroj Bhidayasiri
Pompeyo Stalin Alarcón Vigil
Centre Hospitalier du Quebec
Shaoxing Mashan Street Community Health Service Center
MYOR Ltd.
Dr. Jochen Brack
Worabe Comprehensive Specialiazed Hospital
Saw Swee Hock School of Public Health
Shenzhen Core Medical Technology CO.,LTD.
View Full List
Medical Conditions
Small Intestine Cancer
Urinary Bladder Neurogenic Dysfunction
Memory Disorders
Neuroectodermal Tumor
Root Abscess
Humerus Fracture Displaced Proximal
Pharmacokinetics of Ipragliflozin
Bladder Cancer Recurrent
Macrocephaly Autism Syndrome
Anticoagulant Prophylaxis/Therapy
0.5-14 Year Old Children With Nephroblastoma
Endoscopic Surveillance
Control Nausea and Vomiting
Granulomatous Disease, Chronic
Malignant Tumor of Urinary System (Disorder)
Bladder Recurrence
Parental
Inoperable Stage III Non-small Cell Lung Cancer
Poor Medication Adherence
Atherosclerosis Coronary Artery With Angina Pectoris
View Full List
Drug Interventions
Campath 1H
The drug "Rutan 0.1".
Letrozole
Sparsentan
Everolimus
Varenicline Controlled Release 1.2 mg
Rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
Idelalisib
Biphasic insulin aspart 30
APG2575 800 mg
Vehicle
Fibrin Sealant
Cyclosporine A
Elafibranor 80mg
FTD regimen
Salvinorin A
Ceralasertib
Bupropion Extended Release Oral Tablet
Clozapine 100 mg
SAR408701 (Tusamitamab ravtansine)
View Full List
CROs by country
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Estonia
Contract Research Organizations in Gabon
Contract Research Organizations in Guatemala
Contract Research Organizations in Jamaica
Contract Research Organizations in Netherlands
Contract Research Organizations in Poland
Contract Research Organizations in Rwanda
Contract Research Organizations in Singapore
Contract Research Organizations in Spain
Contract Research Organizations in Uruguay
Contract Research Organizations in Venezuela
CRO list by country
CROs in Kyrgyzstan
SGS
All CROs in Kyrgyzstan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe